Master protocol to assess the long-term safety in kidney transplant recipients who previously received Medeor’s cellular immunotherapy products: the MDR-105-SAE

BACKGROUND: Immunosuppression in transplantation continues to be associated with a multitude of adverse effects. Induction of immune tolerance may be a viable strategy to reduce dependence on immunosuppression. Various trials are currently underway to assess the efficacy of this strategy. However, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Kant, Sam, Kaufman, Dixon B., Micsa, Lenuta, Brennan, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007834/
https://www.ncbi.nlm.nih.gov/pubmed/36899436
http://dx.doi.org/10.1186/s13063-023-07204-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007834/
https://www.ncbi.nlm.nih.gov/pubmed/36899436
http://dx.doi.org/10.1186/s13063-023-07204-4

Ejemplares similares